Bringing the fundamentals into focus…
Back to Jazz Pharmaceuticals plc
How Jazz Pharmaceuticals plc stacks up
JAZZ · against 552 other Healthcare companies listed in US-listed
Overall
65/ 100
Near the top of its peers.
Ranked #68 of 553 · scores higher than 87% of peers
Bars: peers in each 10-point band of the overall score63 peers with an overall score of 60–69, including JAZZ · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around JAZZ| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 3 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 4 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 5 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 62 | 296M USD | 66 | 81 | 91 | 86 | 2 / 2 | |
| 62 | 108.6B USD | 66 | 88 | 55 | 72 | 1 / 2 | |
| 68 | 63.0B USD | 65 | 74 | 73 | 79 | 1 / 2 | |
| 68 | 4.6B USD | 65 | 43 | 84 | 97 | 1 / 2 | |
| 68 | 14.9B USD | 65 | 72 | 80 | 79 | 2 / 2 | |
| 68 | 3.2B USD | 65 | 66 | 61 | 73 | 1 / 2 | |
| 68 | 1.5B USD | 65 | 84 | 81 | 78 | 2 / 2 | |
| 68 | 12.6B USD | 65 | 41 | 67 | 75 | 0 / 2 | |
| 68 | 10.7B USD | 65 | 60 | 84 | 90 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score